Skip to content

Regenerative Treatment of Peri-implantitis

Regenerative Treatment of Peri-implantitis: A Comparison of the Reinforced PTFE Mesh (RPM) and the Collagen Membrane in the Submerged Approach: a Randomized Controlled Clinical Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06153212
Enrollment
32
Registered
2023-12-01
Start date
2023-11-02
Completion date
2027-12-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

The purpose of this study is to study the use of a new type of d-PTFE membrane called reinforced PTFE Mesh (RPM) with dental surgery. The regenerative outcomes of RPM membranes and collagen membrane for surgical reconstructive treatment of peri-implantitis (gum disease around implants) will be compared.

Detailed description

Peri-implantitis is an inflammatory response that leads to irreversible loss of implant supporting bone. This study will investigate the regenerative outcomes obtained with two membranes for surgical reconstructive treatment of peri-implantitis defects when the implant is submerged and primary wound closure is obtained. In one group the newly designed d-PTFE membrane with macropores, known as the RPM membrane will be utilized, which will be compared to the traditional collagen membrane used in the other group. The clinical, radiographic, and histologic outcomes for the regenerative treatment of peri-implantitis when utilizing the same bone graft in combination with either a collagen membrane or the RPM will be evaluated via a parallel-arm randomized controlled clinical trial. 32 patients with peri-implantitis will be recruited and randomized to receive peri-implantitis treatment with either a collagen membrane or an RPM membrane.

Interventions

PROCEDUREMembrane placement with bone grafting

The diseased dental implant will be cleaned and the bone defect will be filled with bone graft and covered by a membrane.

Sponsors

University of Michigan
Lead SponsorOTHER
Osteogenics Biomedical
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Physical status according to the American Society of Anesthesiology (ASA) I or II, which include patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases. * Subjects having at least one dental implant with peri-implantitis according to the definition proposed by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018): * Full-mouth plaque score and full-mouth bleeding score ≤ 20% (measured at four sites per tooth) * Correct 3-dimensional implant positioning, or buccal position ≤ 1 mm * Implants which have been in function for at least 6 months

Exclusion criteria

* A clearly mal-positioned dental implant * Significant interproximal horizontal bone loss (more than 50% of implant fixture length) * A mobile dental implant * Presence of uncontrolled or untreated periodontal disease * More than 2 weeks usage of antibiotics in the past two months * Subjects taking medications known to modify bone metabolism or those that can interfere with the normal wound healing (such as bisphosphonates, corticosteroids, hormone replacement therapy, parathyroid hormone, denosumab, strontium ranelate, etc.), or those with uncontrolled systemic diseases or conditions that may similarly affect the patient's healing (osteoporosis, osteopenia, hyperparathyroidism, Paget's disease, uncontrolled diabetes (HBA1c \> 8)). * Pregnant subjects or individuals attempting to get pregnant (self-reported) * Subjects smoking more than 10 cigarettes a day, or those with a history of drug or alcohol abuse (self-reported) * Subjects unable to maintain adequate oral hygiene (O'Leary plaque index more than 50%) (O'Leary et al., 1972) * Any other contraindications for undergoing periodontal surgery

Design outcomes

Primary

MeasureTime frameDescription
Probing depth measurements in millimetersAbout 5 weeks before baseline surgery and at 8.5 months after baseline surgery.To compare probing depth measurements using a periodontal probe after peri-implantitis treatment
Bone measurements in millimetersBaseline and 8 months after baseline surgeryBone measurements obtained from CBCT

Secondary

MeasureTime frameDescription
Clinical attachment levels in millimeters8 months after baseline surgeryTo compare clinical attachment measurements using a periodontal probe from baseline to the final follow-up visit
Marginal bone levels in millimeters at the implant site8 months after baseline surgeryTo compare marginal bone measurements from periapical radiographs
Volumetric changes of grafted area in cubic millimeters8 months after baseline surgeryTo compare volumetric bone measurements of the grafted areas from CBCT

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMuhammad Saleh, BDS, MSD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026